SEC Form D · filed June 27, 2023
DiaMedica Therapeutics Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (35)
Dominic Cundari · Minneapolis, MNExecJulie Daves · Minneapolis, MNExecTanya N. Lewis · Minneapolis, MNDirectorR. M. Giuffre · Minneapolis, MNDirectorScott Kellen · Minneapolis, MNExecRick Pauls · Minneapolis, MNExec · DirectorCharles P. Semba · Minneapolis, MNDirectorRichard D. Pilnik · Minneapolis, MNDirectorDavid J. Wambeke · Minneapolis, MNExecJames T. Parsons · Minneapolis, MNDirectorRichard M. Kuntz · Minneapolis, MNDirectorCharles Phillips · New York, NYDirectorAndrew S. Tichenor · RICHMOND, VAExecDavid Wasserman · New York, NYDirectorJ.W.G. W. Honeybourne · Stamford, CTDirectorJens Ashton · Provo, UTDirectorPatrick J. Carrol · Stamford, CTExecJeffrey K. Quake · Stamford, CTExecFrancisco D'Souza · New York, NYDirectorKevin Ashton · Lindon, UTDirectorTodd M. Tomlin · Stamford, CTExec · DirectorGary D. Reaves, Ii · Stamford, CTExecKirsten Gruis · Minneapolis, MNExecChristopher J. Henderson · Camarillo, CAExecEdward C. Atsinger · Camarillo, CAExecDavid P. Santrella · Camatillo, CAExecCurtis Burgess · Madison, WIDirectorMatthew Kirk · San Rafael, CAExec · DirectorMichael T. Roth · Greenville, SCDirectorKevin M. Short · Greenville, SCDirectorRichard Goozh · New York, NYExecMartin A. Burian · Vancouver, British Columbia, CanadaDirectorRandy D. Ginn · Bellevue, WADirectorTimothy R. D'Arcy · Boston, MADirectorKirsten Gruis · Minneapolis, MNExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗